期刊文献+

多巴胺与多巴酚丁胺加呋噻米治疗顽固性心力衰竭疗效分析 被引量:3

The Efficacy of Dopamine and Dobutamine in Treatment of Refractory Heart Failure
原文传递
导出
摘要 目的:探讨小剂量多巴胺与多巴酚丁胺加呋噻米治疗顽固性心力衰竭临床疗效及对心功能的影响。方法:选择2008年1月-2012年1月在我科住院的顽固性心力衰竭患者48例,随机分成2组:常规组治疗7天,治疗组以小剂量的多巴胺+多巴酚丁胺与呋噻米治疗7天。结果:常规组显效8例,有效8例,治疗组显效12例,有效11例,治疗组治疗后的SV、LVEF较常规组治疗后改善更明显(P〈0.05)。结论:小剂量多巴胺与多巴酚丁胺加呋噻米治疗难治性心衰能明显改善心功能,是一种有较高的临床价值的治疗方法。 Objective:To discuss the effect on the treatment of refractory heart failure and the cardiac function with small dose of dopamine and dobutamine adding furosemide. Methods:Data was made in 48 patients with refractory heart failure in our hospital from January 2008 to Janu- ary 2012, there were 27 male patients and 21 female patients, the age was between 54 and 78(66.38 ± 7.35) years old. They were divided into two groups, one group was treated with normal method for 7 days and the other one was treated with small dose of dopamine and dobutamine adding furosemide. Results:8 patients in the group treated with normal method played an excellent efficacy and all of them were effective,12 pa- tients in the dopamine group also played an excellent efficacy and 11 of them were effective, the efficacy on SV and LVEF of dopamine group wasmere obvious than the normal treatment greup(p 〈 O. 05). Conclusion:treatment of refractory heart failure with small dose of dopamine and dobutamine adding furosemide can improve the cardiac function and it can be a valuable method on clinical treatment.
作者 胡秀容
出处 《中国伤残医学》 2013年第10期35-36,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 顽固性心力衰竭 临床疗效 心功能 refractory heart failure clinical treatment cardiac function.
  • 相关文献

参考文献3

二级参考文献22

  • 1Roger V L, Go A S, Lloyd-Jones D M, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation, 2012, 125(1):e2-e220.
  • 2Roger V L, Weston S A, Redfield M M, et al. Trends in heart failure incidence and survival in a community-based population..lAMA, 2004, 292(3):344-50.
  • 3Francis G S, Benedict C, Johnstone D E, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation, 1990, 82(5): 1724-9.
  • 4Eshaghian S, Horwich T B, and Fonarow G C. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol, 2006, 97(12): 1759-64.
  • 5Ahmed A, Husain A, Love T E, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J, 2006, 27(12): 1431-9.
  • 6Domanski M, Norman J, Pitt B, et al. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfimction (SOLVD). JAm Coil Cardiol, 2003, 42(4):705-8.
  • 7Ahmed A, Young J B, Love T E, et al. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure. IntJCardiol, 2008, 125(2):246-53.
  • 8Cooper H A, Dries D L, Davis C E, et al. Diuretics and risk of arrhythmic death in patients with left ventrieular dysfunction. Circulation, 1999, 100(12):1311-5.
  • 9Brater D C. Diuretic therapy. N Engl J Med, 1998, 339(6):387-95.
  • 10Hasselblad V, Gattis Stough W, Shah M R, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur JHeart Fail 2007, 9(10): 1064-9.

共引文献38

同被引文献27

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部